Cytopoint 20 mg/ml Solution for Injection for Dogs

• Target species: Dogs
• Active substances: Lokivetmab
• Pharmaceutical form: Solution for injection
• Therapeutic group: Immunomodulator
• Authorisation route: National
• Legal category: POM-V
• Controlled drug status: Not a controlled drug
• Marketing Authorisation holder: Zoetis UK Limited
• Distributors: <span>Zoetis UK Limited</span>
• Territory: Great Britain
• SPC: https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_2169257.PDF
• UKPAR: